CannaPharmaRx Inc
OTC:CPMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CannaPharmaRx Inc
OTC:CPMD
|
CA |
|
ASL Marine Holdings Ltd
SGX:A04
|
SG |
|
Alkim Kagit Sanayi ve Ticaret AS
IST:ALKA.E
|
TR |
|
N
|
NioCorp Developments Ltd
NASDAQ:NB
|
US |
|
A
|
Audax Renovables SA
SWB:54F
|
ES |
|
A
|
Advanced Process Systems Corp
KOSDAQ:265520
|
KR |
|
T
|
Tan Cang Logistics and Stevedoring JSC
VN:TCL
|
VN |
|
J
|
Jiayin Group Inc
NASDAQ:JFIN
|
CN |
|
C
|
Chi Kan Holdings Ltd
HKEX:9913
|
HK |
Profitability Summary
CannaPharmaRx Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
Margins
Earnings Waterfall
CannaPharmaRx Inc
Margins Comparison
CannaPharmaRx Inc Competitors
| Country | Company | Market Cap |
Gross Margin |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|---|
| CA |
|
CannaPharmaRx Inc
OTC:CPMD
|
2.5m USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
855.1B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.7B USD |
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
229B GBP |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD |
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
230.8B CHF |
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.6B USD |
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
GSK plc
XETRA:GS71
|
99.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Return on Capital
Return on Capital Comparison
CannaPharmaRx Inc Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| CA |
|
CannaPharmaRx Inc
OTC:CPMD
|
2.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
855.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
229B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
230.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
GSK plc
XETRA:GS71
|
99.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
